A group that includes UCSF, the City and County of San Francisco, and health care and community organizations has launched the San Francisco Cancer Initiative, a major public health effort to reduce cancer in San Francisco.
A previously unidentifiable type of low-grade inflammation may explain why common anti-inflammatory drugs such as aspirin have shown promise against some types of cancer – even when patients don’t display typical signs of inflammation.
The new UCSF Center for BRCA Research – which spans basic and translational research, clinical care and education – provides a one-stop resource for patients and individuals who carry BRCA1 and BRCA2 mutations.
The UCSF community is deeply saddened by the passing of Andrew S. Grove, former CEO and chairman of Intel Corp., who applied his drive for innovation to advocacy for advancements in health care and the treatment of cancer and Parkinson’s disease.
A study that tracked tens of thousands of midlife and older men for more than 20 years has found that vigorous exercise and other healthy lifestyle habits may cut their chances of developing a lethal type of prostate cancer by up to 68 percent.
After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, according to a UCSF study.
UCSF Medical Center is one of the nation’s premier hospitals for the 14th consecutive year, ranking as the eighth best hospital in the country in the 2015-2016 Best Hospitals survey from U.S. News & World Report.